RT Journal Article
SR Electronic
T1 Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
JF Heart
JO Heart
FD BMJ Publishing Group Ltd and British Cardiovascular Society
SP 707
OP 709
DO 10.1136/hrt.2004.057190
VO 91
IS 6
A1 Doehner, W
A1 Anker, S D
YR 2005
UL http://heart.bmj.com/content/91/6/707.abstract
AB A substantial body of evidence has accumulated to suggest a role for the xanthine oxidase metabolic pathway in the pathophysiology of chronic heart failure and other cardiovascular diseases